BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4282386)

  • 21. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 22. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine metabolism in human brain.
    Robinson DS; Sourkes TL; Nies A; Harris LS; Spector S; Bartlett DL; Kaye IS
    Arch Gen Psychiatry; 1977 Jan; 34(1):89-92. PubMed ID: 13761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 25. Regional brain variations of tryptophan, monoamines, monoamine oxidase activity, plasma free and total tryptophan during the estrous cycle of the rat.
    Kueng W; Wirz-Justice A; Menzi R; Chappuis-Arndt E
    Neuroendocrinology; 1976; 21(4):289-96. PubMed ID: 1035790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates.
    Brown RM; Crane AM; Goldman PS
    Brain Res; 1979 May; 168(1):133-50. PubMed ID: 36962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypersomnia by isthmic lesion in cat. Study of the metabolism of cerebral monamines].
    Blondaux C; Buda M; Petitjean F; Pujol JF
    Brain Res; 1975 May; 88(3):425-37. PubMed ID: 1170005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of ( 14 C)-serotonin in the caudate nucleus, hypothalamus and reticular formation of the rat after ethanol administration.
    Tytell M; Myers RD
    Biochem Pharmacol; 1973 Feb; 22(3):361-72. PubMed ID: 4568931
    [No Abstract]   [Full Text] [Related]  

  • 30. Biogenic monoamines in the cyclostome and lower vertebrate brain.
    Baumgarten HG
    Prog Histochem Cytochem; 1972; 4(1):1-90. PubMed ID: 4354409
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain acetylcholinesterase in Parkinson's disease.
    Rinne UK; Riekkinen P; Sonninen V; Laaksonen H
    Acta Neurol Scand; 1973; 49(2):215-26. PubMed ID: 4718190
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of ketamine upon norepinephrine and dopamine levels in rabbit brain parts.
    Glisson SN; el-Etr AA; Bloor BC
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):149-52. PubMed ID: 995210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 35. The dopamine hypothesis of schizophrenia: a review.
    Meltzer HY; Stahl SM
    Schizophr Bull; 1976; 2(1):19-76. PubMed ID: 779020
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoamine changes in the brain of cats during slow-wave sleep.
    Kovacević R; Radulovacki M
    Science; 1976 Sep; 193(4257):1025-7. PubMed ID: 948760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 38. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
    Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insomnia and cerebral metabolism of serotonin in cats: study of in vitro synthesis and release of serotonin 18 hours after destruction of the raphe nuclei].
    Pujol JF; Sordet F; Petitjean F; Germain D; Jouvet M
    Brain Res; 1972 Apr; 39(1):137-49. PubMed ID: 4537239
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Kosaka K; Iizuka R
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.